Skip to content

Clinical trials

Heart Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Country / region: South Korea Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20112
20121
20131
20142
20161
20171
20183
20192
20201
20213
20223
20234
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting7
Terminated3
Unknown status3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chonnam National University Hospital2
Eidos Therapeutics, a BridgeBio company2
GlaxoSmithKline2
HUINNO Co., Ltd2
Seung-Jung Park2
Taewoong Medical Co., Ltd.2
Weill Medical College of Cornell University2
Abbott Medical Devices1
Alexion Pharmaceuticals, Inc.1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases31
Cardiovascular Diseases12
Coronary Artery Disease9
Coronary Disease8
Acute Coronary Syndrome6
Myocardial Ischemia5
Myocardial Infarction4
Stroke4
Angina Pectoris3
Atherosclerosis3

Trials

Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.